The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032

The Business Research Company’s osteoporosis drugs market report forecasts the osteoporosis drugs market size to grow to $17.58 Billion by 2027, with a CAGR (compound annual growth rate) of more than 4%.

Learn More On The Osteoporosis Drugs Market Report 2023 – https://www.thebusinessresearchcompany.com/report/osteoporosis-drugs-global-market-report

Osteoporosis Drugs Market Size Forecast
The global osteoporosis drugs market is expected to grow from $13.79 billion in 2022 to $14.60 billion in 2023 at a compound annual growth rate (CAGR) of 5.84%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The global osteoporosis drugs market size is expected to reach $17.58 billion in 2027 at a CAGR of 4.7%.

North America held the largest osteoporosis drugs market share.

Key Osteoporosis Drugs Market Driver ­– Increase In The Prevalence Of Osteoporosis
For example, according to estimates provided by Amgen, a US-based biotechnology company, in May 2022, osteoporosis causes around 1.5 million fractures in the United States each year, costing $19 billion in associated expenditures. Furthermore, from 2018 to 2040, the annual number of fractures caused by osteoporosis is anticipated to increase by 68%, from 1.9 million to 3.2 million. As a result, the rising prevalence of osteoporosis is propelling the osteoporosis medications market forward.

Request for A Sample Of The Global Osteoporosis Drugs Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=9102&type=smp

Key Osteoporosis Drugs Market Trend – Product Innovations
Major industry players are moving towards the usage of novel solutions for the osteoporosis medicine market. For example, in January 2020, Zobrius Pharma, a Norwegian manufacturer of one-of-a-kind health supplements, released Maxx-Calzium, a new nutritional supplement. It serves as an alternative to the inorganic calcium found in limestone, which is commonly found in dietary supplements. The main ingredient in this new product is Norilia eggshell calcium, together with vitamin D3 and vitamin K2, which can assist the body absorb calcium.

Osteoporosis Drugs Market Segment
1) By Type: Bisphosphonates, Selective Estrogen Receptor Modulators (SERMs), RANK Ligand Inhibitors
2) By Administration: Oral, Injectable
3) By Distribution Channel: Retail Pharmacies, Hospital Pharmacies, Online Sales
4) By Application: Primary Osteoporosis, Secondary Osteoporosis

Osteoporosis Drugs Market Major Players and Strategies
Major players in the osteoporosis drugs market are Eli Lilly and Company, Amgen Inc., F. Hoffmann La Roche Ltd., Merck & Co. Inc., Novartis AG, Pfizer Inc., Teva Pharmaceutical Industries Ltd., Novo Nordisk A/S, GlaxoSmithKline PLC, Actavis PLC, Enzene Biosciences Ltd., Theramex, Viatris Inc., Ligand Pharmaceuticals Incorporated, and UCB S.A.

Major industry players are embracing fresh solutions for the osteoporosis medicine market. For example, Maxx-Calzium, a new nutritional supplement, was released in January 2020 by Zobrius Pharma, a Norwegian developer of one-of-a-kind health supplements. It can be used instead of the inorganic calcium found in limestone, which is typically available in dietary supplements. Norilia eggshell calcium is the key element in this new product, along with vitamin D3 and vitamin K2, which can help the body absorb calcium.

The Osteoporosis Drugs Global Market Report 2023 covers regional data on osteoporosis drugs market size, osteoporosis drugs market trends and drivers, opportunities, strategies, and osteoporosis drugs market competitor analysis. The countries covered in the osteoporosis drugs market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA, and the major seven regions are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

Osteoporosis treatments are medications that increase bone mineral density and help to prevent fractures. It includes fracture treatment and prevention, as well as the use of medications to strengthen bones.

View More Reports Related To The Osteoporosis Drugs Market –
Drugs For Erectile Dysfunction Global Market Report 2023
Drugs For Immunotherapy Global Market Report 2023
Drugs For Hormonal Replacement Therapy Global Market Report 2023

Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]

Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: